A systematic review and meta-analysis of studies analyzing the relevance of FSCN1 in five different carcinomas (breast, colorectal, esophageal, gastric, and lung) by IHC reported that FSCN1 correlates with a high risk of disease progression in breast and colorectal cancers [48]. The gene discussed is FSCN1; the disease is carcinoma.